Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with β-thalassaemia major and the effect of GH treatment

Clinical Endocrinology

Volumn 48, Issue 5, 1998, Pages 641-646

  Low, L C K ^a   Postel Vinay, M C ^b   Kwan, E Y W ^a   Cheung, P T ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENCE; ADULT; ARTICLE; BETA THALASSEMIA; CHILD; CHILDHOOD; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GROWTH ACCELERATION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONE SENSITIVITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE;

EID: 0031778827     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00470.x     Document Type: Article

References (27)

1. Argente, J., Barrios, V., Pozo, J., Munoz, M.T., Hervas, F., Stene, M. & Hernandez, M. (1993) Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatriac population: age and sex related changes. Journal of Clinical Endocrinology and Metabolism, 77, 1522-1528.
2. Baumann, G., Shaw, M.A. & Amburn, K. (1989) Regulation of plasma growth hormone-binding proteins in health and disease. Metabolism, 38, 683-689.
3. Borgna-Pignatti, C., Zurlo, M.G., DeStefano, I., Boffa, C., DeSanctis, V., DiPalma, A., DiGregorio, L., Melevendi, C., Piga, A. & Sabato, V. (1993) Outcome of thalassaemia treated with conventional therapy. Bone Marrow Transplant, 12 (suppl.), 2-4.
4. De Virgillis, D., Congio, M., Frau, F., Argiolu, F., Diana, G., Cucca, F., Varsi, A., Sanna, G., Podda, G., Fodde, M., Pirastu, G.F. & Cao, A. (1988) Deferoxamine-induced growth retardation in patients with thalassemia major. Journal of Pediatrics, 113, 661-669.
5. Herington, A.C., Werther, G.A., Mathews, R.N. & Burger, H.G. (1981) Studies on the possible mechanism for deficiency of non-suppressible insulin-like activity in thalassemia major. Journal of Clinical Endocrinology and Metabolism, 52, 393-398.
6. Hochberg, Z., Hertz, P., Colin, V., Ish-Shalom, S., Yeshurun, D., Youdim, M.B.H. & Amit, T. (1992) The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulilike growth factor 1 (IGF-I) and IGF-I receptors in obesity and anorexia nervosa. Metabolism, 41, 106-112.
7. Kwan, E.Y.W., Lee, A.C.W., Li, A.M.C., Tam, S.C.F., Chan, C.F., Lau, Y.L. & Low, L.C.K. (1995a) A cross-sectional study of growth, puberty and endocrine function in patients with thalassaemia major in Hong Kong. Journal of Paediatrics and Child Health, 31, 83-87.
8. Kwan, E.Y.W., Tam, S.C.F., Karlberg, J., Lam, K.S.L. & Low, L.C.K. (1995b) The metabolic effects of growth hormone in children with β-thalassaemia major. Abstract. 77th Endocrine Society Meeting, Washington, USA, p. 156.
9. Laron, Z., Klinger, B., Blum, W.F., Silbergeld, A. & Ranke, M.B. (1992) IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I. Clinical Endocrinology, 36, 301-304.
10. Leger, J., Girot, R., Crosnier, H., Postel-Vinay, M.C. & Rappaport, R. (1989) Normal growth hormone (GH) response to GH-releasing hormone in children with thalassemia major before puberty: a possible age related effect. Journal of Clinical Endocrinology and Metabolism, 69, 453-456.
11. Leung, S.S.F., Law, J.T., Xu, Y.Y., Tse, L.Y., Huen, K.F., Wong, G.W.K., Law, W.Y., Yeung, V.T., Yeung, W.K. & Leung, N.K. (1996) Secular changes in standing height, sitting height and sexual maturation of Chinese - the Hong Kong Growth Study 1993. Annals of Human Biology, 23, 297-306.
12. Low, L.C.K., Kwan, E.Y.W., Cheung, P.T., Li, A., Ha, S.Y., Lau, Y.L. & Karlberg, J. (1998) The effect of platyspondyly and lack of pubertal growth spurt on the stature of children with β-thalassaemia major. Chinese Medical Journal, in press.
13. Low, L.C.K., Kwan, E.Y.W., Lim, Y.J., Lee, A.C.W., Tam, CF. & Lam, K.S.L. (1995) Growth hormone treatment of short Chinese children with β-thalassaemia major without GH deficiency. Clinical Endocrinology, 42, 359-363.
14. Low, L.C.K. (1997) Growth, puberty and endocrine function in beta-thalassaemia major. Journal of Paediatric Endocrinology and Metabolism, 10, 175-184.
15. Martha Jr, P.M., Rogol, A.D., Blizzard, R.M., Shaw, M.A. & Baumann, G. (1991) Growth hormone-binding protein activity is inversely related to 24-hour growth hormone release in normal boys. Journal of Clinical Endocrinology and Metabolism, 73, 175-181.
16. Martha, P.M., Reiter, E.O., Davila, N., Shaw, M.A., Holcombe, J.H. & Baumann, G. (1992) Serum growth hormone (GH)-binding protein/receptor: an important determinant of GH responsiveness. Journal of Clinical Endocrinology and Metabolism, 75, 1464-1469.
17. Mauras, N., Carlsson, L.M.S., Murpy, S. & Merimee, T.J. (1994) Growth hormone-binding protein levels: studies of children with short stature. Metabolism, 43, 357-359.
18. Olivie, M.A.A., Garcia-Mayor, R.V., Leston, D.G., Sousa, T.R., Dominguez, A.S., Alvarez-Novoa, R. & Cortizas, J.A. (1995) Serum insulin-like growth factor (IGF) binding protein-3 and IGF-I levels during childhood and adolescence. A cross-sectional study. Pediatric Research, 38, 149-155.
19. Olivieri, N.F., Nathan, D.G., MacMillan, J.H., Wayne, A.S., Liu, P.P., McGee, A., Martin, M., Koren, G. & Cohen, A.R. (1994) Survival in medically treated patients wiih homozygous β-thalassemia. New England Journal of Medicine, 331, 574-578.
20. Postel-Vinay, M.C., Girot, R., Leger, J., Hocquette, J.F., McKelvie, P., Amar Cortesee. A. & Rappaport, R. (1989) No evidence for a defect in growth hormone binding to liver membrane in thalassemia major. Journal of Clinical Endocrinology and Metabolism, 68, 94-98.
21. Postel-Vinay, M.C., Tar, A., Hocquette, J.F., Clot, J.P., Fontoura, M., Brauner, R. & Rappaport, R. (1991) Human plasma growth hormone (GH)-binding proteins are regulated by GH and testosterone. Journal of Clinical Endocrinology and Metabolism, 73, 197-202.
22. Rodda, C.P., Reid, E.D., Johnson, S., Doery, J., Mathews, R. & Bowden, D.K. (1995) Short stature in homozygous β-thalassaemia is due to disproportionate truncal shortening. Clinical Endocrinology, 42, 587-592.
23. Rosenfeld, R.G., Pham, H., Cohen, P., Fielder, P., Gargosky, S.E., Muller, H., Nonoshita, L. & Oh, Y. (1994) Insulin-like growth factor binding proteins and their regulation. Acta Paediatrica, 399 (suppl.) 154-158.
24. Silberged, A., Lazar, L., Erster, B., Keret, R., Tepper, R. & Laron, Z. (1989) Serum growth hormone binding protein activity in healthy neonates, children and young adults: correlation with age, height and weight. Clinical Endocrinology, 31, 295-303.
25. Tar, A., Hocquette, J.F., Souberhielle, J.C., Clot, J.P., Brauner, R. & Postel-Vinay, M.C. (1990) Evaluation of the growth hormone-binding proteins in human plasma using HPLC-gel filtration. Journal of Clinical Endocrinology Metabolism, 71, 1202-1207.
26. Trivedi, B. & Daughaday, W.H. (1988) Release of growth hormone binding protein from 1M-9 lymphocytes by endopeptidase is dependent on sulfhydryl group inactivation. Endocrinology, 123, 2201-2206.
27. Weissberger, A.J., Ho, K.K.Y. & Lazarus, L. (1991) Contrasting effects of oral and transdermal routes of oestrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor 1, and GH-binding protein in postmenopausal women. Journol of Clinical Endocrinology and Metabolism, 72, 374-381.